The medication is gradually increased over several weeks, starting at 0.25 mg weekly for the first four weeks, then typically increasing to 0.5 mg, with potential further titration to 1 mg or 2 mg depending on glycaemic control and tolerability
Be wary of domestic vendors selling at suspiciously low prices with no COA: verifiable purity is worth a few extra dollars to protect your research
Documenting Results for Reproducibility Because peptide research depends heavily on consistent handling, many labs standardize a documentation template covering batch number, storage conditions, dose timing, and any deviations from protocol
Proper storage is critical for maintaining the structural integrity and biological activity of peptide-based injectable medicines
Gaykema RP, Newmyer BA, Ottolini M, Raje V, Warthen DM, Lambeth PS, et al
Blood 68 , 627632 (1986)